Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Holding in Company

11th Nov 2010 11:49

RNS Number : 0282W
Silence Therapeutics PLC
11 November 2010
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Silence Therapeutics, PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

x

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

Instructions for one of our institutional clients to do their own voting

3. Full name of person(s) subject to thenotification obligation: iii

Roche Finance Ltd

4. Full name of shareholder(s)  (if different from 3.):iv

-

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

10th of November,2010

6. Date on which issuer notified:

11th of November,2010

7. Threshold(s) that is/are crossed orreached: vi, vii

3% (new holding less than 3%)

 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

GB00084

8426962

0

7426962

-

-

2.65%

 

33350

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

2.65%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

Name of Company/Fund

Number of Shares

% of issued share capital

 

 

 

 

 

 

TOTAL

Proxy Voting:

10. Name of the proxy holder:

-

11. Number of voting rights proxy holder will ceaseto hold:

-

12. Date on which proxy holder will cease to holdvoting rights:

-

13. Additional information:

14. Contact name:

Felix Kobel

15. Contact telephone number:

+4161688879

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLGGGQCGUPUGGG

Related Shares:

SLN.L
FTSE 100 Latest
Value8,726.01
Change-52.04